Institut Mérieux – International Society for Infectious Diseases

Young Investigator Award - 2018

Antibiotic resistance (ABR) is a major public health issue worldwide and innovative approaches to tackling resistant bacteria in humans, animals and the environment are urgently needed. For many years, the Institut Mérieux and its entities have been committed to the fight against antibiotic resistance and to the control of the spread of resistant infections. In order to provide an incentive for promising young investigators working in the field of ABR, Institut Mérieux allocates several awards worldwide to researchers or clinicians at the beginning of their carrier in recognition of a major achievement having significant impact on the handling of ABR.


In 2018, Institut Mérieux and the International Society for Infectious Diseases will award a joint Young Investigator Award of 10,000 Euros that will be given to the awardee during the 18th International Congress on Infectious Diseases/XVIII Congreso SADI in Buenos Aires, Argentina, March 1 to 4, 2018. Recognizing that the rising threat of AMR requires a multisectoral “One Health” approach, applications from young investigators from the human, veterinary, and environmental fields will be considered.


Application documents must be submitted in English.

Applicants will be informed by February 15, 2018


Selection criteria:


·       Young investigator living and working in a Latin American country.


·       Less than 10 years of working experience after their postgraduate qualification in clinical infectious diseases, microbiology/pathology, veterinary medicine, environmental sciences, public health, or epidemiology.


·       Serving in a hospital, in the community, or in a relevant research institution on a full-time basis as infectious diseases clinician, non-specialist clinician, microbiologist (pathologist), researcher, veterinarian, environmentalist, public health official, or epidemiologist.


·       Involved and made outstanding contribution(s) in research and/or patient management with a national impact in the field of bacterial antibiotic resistance (excluding tuberculosis). Indeed, this award is specifically made on the basis of outstanding contribution to the field, rather than the strength of proposed future research.


·       Indicators of impact could be either publication(s) in prominent international journals and / or implementation of guidelines / protocols having led to significant improvements in the following areas:

o   Development of new tools / approaches in tackling antibiotic resistance.

o   Adoption of innovative approaches for controlling antibiotic resistance.

o   Any actions having led to improved control / measurable reduction of resistant infections in the healthcare setting, veterinary field, animal husbandry, or agriculture.